Skip to content

The Association Between Loneliness and Substance Use

The Association Between Loneliness and Substance Use

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04938492
Enrollment
125
Registered
2021-06-24
Start date
2021-08-12
Completion date
2023-07-01
Last updated
2025-02-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Loneliness, Opioid Use

Brief summary

The proposed study will determine if cognitive behavioral therapy will help improve loneliness in people who use opioids.

Detailed description

The proposed study will be the first to assess the cognitive, affective, and behavioral pathways by which loneliness impacts opioid use. Individuals with an opioid use disorder (OUD) reporting loneliness will be randomized to either a 6-session Cognitive- Behavioral Therapy for loneliness (CBT-L) or a 6-session education control condition, both delivered via telehealth. Telehealth delivery can be easily implemented and can increase reach and access to individuals not engaged in treatment. We will use an established brief CBT manual to address loneliness. We will assess loneliness, negative affect (i.e., depression and anxiety), and the quality and quantity of social interactions prior to, during, and after the intervention to evaluate the subsequent impact on opioid use trajectories. Participant will complete questionnaires pre-treatment, post-treatment, and at 1- and 2-months posttreatment.

Interventions

BEHAVIORALCognitive Behavioral Therapy for loneliness (CBT-L)

6 sessions focused on addressing thoughts, emotions, and behaviors that maintain feeling alone as a way to reduce loneliness and substance use.

BEHAVIORALPhysical Health Education Training (PHET)

Health education provides information on the importance and benefits of and guidelines for living a healthy lifestyle.

Sponsors

National Institute on Drug Abuse (NIDA)
CollaboratorNIH
University of Rochester
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Must be ages 18+ * Understand English * Have internet access * Screen positive for an active OUD on the OUD Module of the Structured Clinical Interview for DSM-5 (Diagnostic & Statistical Manual of Mental Disorder, 5th edition) Research Version (SCID-5-RV) * Screen positive for loneliness by scoring at least a T-score \> 60 on the NIH Toolbox Loneliness Scale

Exclusion criteria

* Consistent with previously used telehealth-delivered assessments, we will exclude any participant with cognitive impairment as measured by the Blessed Orientation-Memory-Concentration Test (BOMC) * Potential participants who are in the process of detoxifying as measured by the Subjective Opiate Withdrawal Scale will also be excluded

Design outcomes

Primary

MeasureTime frameDescription
Mean Change in Lonelinessbaseline to 2 months post-treatmentLoneliness will be measured using the University of California-Los Angeles (UCLA) Loneliness Scale. A 20-item scale designed to measure one's subjective feelings of loneliness as well as feelings of social isolation. Participants rate each item as 1 (never), 2 (rarely), 3 (sometimes) or 4 (often). The scores range from 20-80 with higher scores indicating worse outcome.

Secondary

MeasureTime frameDescription
Mean Change in Percent Days Abstinent From Opioidsbaseline to 2 months post-treatmentParticipants will complete a calendar indicating the type and frequency of drug use.
Mean Change in Percent Days Abstinent From Other Drugsbaseline to 2 monthsParticipants will complete a calendar indicating the type and frequency of drug use.
Mean Change in Social Supportbaseline to 2 months post-treatmentDuke Social Support Index assesses several domains of perceived social support, including social network size, social interaction, social satisfaction, and instrumental social support. Higher scores indicate a higher quality of social interactions or perceived social support. Scores range from 6 to 18.

Countries

United States

Participant flow

Recruitment details

Potential participants were recruited from social networking platforms. Recruitment started 08/2021.

Pre-assignment details

Participants in both conditions receive a baseline assessment and then are randomized to either CBT or Health Education.

Participants by arm

ArmCount
Cognitive Behavioral Therapy (CBT)
CBT delivered over the course of 6, \ 45 minute sessions delivered via telehealth. Cognitive Behavioral Therapy for loneliness (CBT-L): 6 sessions focused on addressing thoughts, emotions, and behaviors that maintain feeling alone as a way to reduce loneliness and substance use.
63
Health Education
Health education sessions delivered over the course of 6, \ 45 minute sessions delivered via telehealth. Physical Health Education Training (PHET): Health education provides information on the importance and benefits of and guidelines for living a healthy lifestyle.
62
Total125

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyLost to Follow-up1718

Baseline characteristics

CharacteristicCognitive Behavioral Therapy (CBT)Health EducationTotal
Age, Continuous45.5 years
STANDARD_DEVIATION 12.8
42.2 years
STANDARD_DEVIATION 9.7
43.8 years
STANDARD_DEVIATION 11.4
Duke Social Support Index-Perceived Social Support11.4 units on a scale
STANDARD_DEVIATION 2.9
11.7 units on a scale
STANDARD_DEVIATION 3.1
11.5 units on a scale
STANDARD_DEVIATION 3
Ethnicity (NIH/OMB)
Hispanic or Latino
5 Participants4 Participants9 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
58 Participants58 Participants116 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Percent days abstinent from opioids40.7 percentage of days
STANDARD_DEVIATION 36.6
33.0 percentage of days
STANDARD_DEVIATION 34.6
36.9 percentage of days
STANDARD_DEVIATION 35.7
Race (NIH/OMB)
American Indian or Alaska Native
2 Participants1 Participants3 Participants
Race (NIH/OMB)
Asian
1 Participants2 Participants3 Participants
Race (NIH/OMB)
Black or African American
13 Participants19 Participants32 Participants
Race (NIH/OMB)
More than one race
1 Participants1 Participants2 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
1 Participants0 Participants1 Participants
Race (NIH/OMB)
White
45 Participants39 Participants84 Participants
Sex: Female, Male
Female
36 Participants36 Participants72 Participants
Sex: Female, Male
Male
27 Participants26 Participants53 Participants
UCLA Loneliness Scale58.0 units on a scale - loneliness
STANDARD_DEVIATION 9.1
58.5 units on a scale - loneliness
STANDARD_DEVIATION 7.9
58.2 units on a scale - loneliness
STANDARD_DEVIATION 8.5

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 630 / 62
other
Total, other adverse events
1 / 631 / 62
serious
Total, serious adverse events
0 / 630 / 62

Outcome results

Primary

Mean Change in Loneliness

Loneliness will be measured using the University of California-Los Angeles (UCLA) Loneliness Scale. A 20-item scale designed to measure one's subjective feelings of loneliness as well as feelings of social isolation. Participants rate each item as 1 (never), 2 (rarely), 3 (sometimes) or 4 (often). The scores range from 20-80 with higher scores indicating worse outcome.

Time frame: baseline to 2 months post-treatment

ArmMeasureValue (MEAN)Dispersion
Cognitive Behavioral Therapy (CBT)Mean Change in Loneliness-8.3 score on a scaleStandard Deviation 14.9
Health EducationMean Change in Loneliness-10.3 score on a scaleStandard Deviation 12.5
p-value: >0.05Latent growth modeling
Secondary

Mean Change in Percent Days Abstinent From Opioids

Participants will complete a calendar indicating the type and frequency of drug use.

Time frame: baseline to 2 months post-treatment

ArmMeasureValue (MEAN)Dispersion
Cognitive Behavioral Therapy (CBT)Mean Change in Percent Days Abstinent From Opioids40 percentage of days (abstinent/total)Standard Deviation 43
Health EducationMean Change in Percent Days Abstinent From Opioids20 percentage of days (abstinent/total)Standard Deviation 30
p-value: <0.001Latent growth modeling
Secondary

Mean Change in Percent Days Abstinent From Other Drugs

Participants will complete a calendar indicating the type and frequency of drug use.

Time frame: baseline to 2 months

ArmMeasureValue (MEAN)Dispersion
Cognitive Behavioral Therapy (CBT)Mean Change in Percent Days Abstinent From Other Drugs30 percentage of days (abstinent/total)Standard Deviation 42
Health EducationMean Change in Percent Days Abstinent From Other Drugs14 percentage of days (abstinent/total)Standard Deviation 33
p-value: <0.01Latent growth modeling
Secondary

Mean Change in Social Support

Duke Social Support Index assesses several domains of perceived social support, including social network size, social interaction, social satisfaction, and instrumental social support. Higher scores indicate a higher quality of social interactions or perceived social support. Scores range from 6 to 18.

Time frame: baseline to 2 months post-treatment

ArmMeasureValue (MEAN)Dispersion
Cognitive Behavioral Therapy (CBT)Mean Change in Social Support1.6 score on a scaleStandard Deviation 3.4
Health EducationMean Change in Social Support1.0 score on a scaleStandard Deviation 3
p-value: >0.05Latent growth modeling

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026